Pharmaceutical Technology

AUGUST 16, 2022

In 2019, Daiichi Sankyo entered a global development and commercialisation agreement with AstraZeneca for Daiichi Sankyo’s lead antibody-drug conjugate (ADC), Enhertu (trastuzumab deruxtecan), in a deal worth $6.9bn. GlobalData estimates that global annual sales for datopotamab deruxtecan in the NSCLC setting will exceed $500m in 2028.

Food and Drug Administration 59

Food and Drug Administration Sales Patients Food 59

Pharmaceutical Technology

JANUARY 19, 2023

Antigens such as CD123 and CD33, despite being markers of myeloid cells, are shared with their healthy counterparts, and myeloablation following their depletion often leads to detrimental clinical outcomes. NiCord’s biologics license application is currently being investigated by the FDA with a review date set by May 2023.

Marketing 52

Marketing FDA Sales Management 52

Medico Reach

MARCH 24, 2023

Immunotherapy To combat the deadly disease, numerous pharmaceutical companies are actively pursuing FDA approval, which reflects its enormous market potential. billion by 2028. Nanotechnology By 2028, the Nanotechnology Medicines Delivery Market is expected to be $141.2 These may include FDA grants and commercial success.

Marketing 52

Marketing Medicine Healthcare Healthcare 52

Medico Reach

MARCH 24, 2023

Immunotherapy To combat the deadly disease, numerous pharmaceutical companies are actively pursuing FDA approval, which reflects its enormous market potential. billion by 2028. Nanotechnology By 2028, the Nanotechnology Medicines Delivery Market is expected to be $141.2 These may include FDA grants and commercial success.

Marketing 52

Marketing Medicine Healthcare Healthcare 52

Pharmaceutical Technology

MARCH 22, 2023

Substance use disorders leave people with long-term negative mental and physical health implications and can lead to death. The device received Breakthrough Device Designation from the US Food and Drug Administration (FDA) in December 2020 as no standard of care for the condition existed.

Food and Drug Administration 52

Food and Drug Administration Healthcare Healthcare Medical 52

European Pharmaceutical Review

FEBRUARY 14, 2023

On the importance of the vaccine, she shared: “Respiratory diseases are a major public health priority given they… are a leading cause of hospitalisation.” In August 2021, mRNA-1345 gained Fast Track designation from the US Food and Drug Administration (FDA) in adults over 60 years old.

Food and Drug Administration 90

Food and Drug Administration Medicine Safety Consulting 90

Medico Reach

OCTOBER 17, 2022

million by 2028. However, this can lead to several issues, such as: Implantation resistance due to reactionary metabolism Allergic reactions to the nickel component found in stainless steel composites Widespread bone destruction due to immunological responses to cobalt particles. The US-based Enovis is leading this new development.

Medical 98

Medical Food and Drug Administration Healthcare Healthcare 98

pharmaphorum

OCTOBER 18, 2022

Eli Lilly has agreed to buy hearing loss gene therapy developer Akouos in a deal that could value the company at around $610 million – if its lead candidate progresses as hoped in the clinic. per month if conditions are not met, until the end of 2028 when they will all expire. The buyout – for $12.50

Medicine 52

Medicine FDA Patients Pharma 52

Medico Reach

OCTOBER 17, 2022

million by 2028. However, this can lead to several issues, such as: Implantation resistance due to reactionary metabolism Allergic reactions to the nickel component found in stainless steel composites Widespread bone destruction due to immunological responses to cobalt particles. The US-based Enovis is leading this new development.

Medical 52

Medical Food and Drug Administration Healthcare Healthcare 52

World of DTC Marketing

APRIL 7, 2022

The seventh leading cause of death in the United States, diabetes costs $327 billion in medical costs and lost work and wages. By 2028, these costs are expected to climb to $6.2 Food and Drug Administration (FDA). About 1 in 5 people with diabetes don’t know they have it. THREAT 3: RISING HEALTHCARE COSTS.

Healthcare 215

Healthcare Healthcare Food and Drug Administration Government 215